Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,800
Closed -$305K 1145
2022
Q1
$305K Hold
4,800
﹤0.01% 1103
2021
Q4
$308K Sell
4,800
-900
-16% -$57.1K ﹤0.01% 1083
2021
Q3
$329K Hold
5,700
﹤0.01% 1129
2021
Q2
$363K Buy
+5,700
New +$309K ﹤0.01% 1144
2020
Q2
Sell
-64,800
Closed -$864K 1252
2020
Q1
$864K Sell
64,800
-3,900
-6% -$131K ﹤0.01% 877
2019
Q4
$3.29M Buy
68,700
+21,600
+46% +$896K 0.01% 723
2019
Q3
$1.89M Sell
47,100
-200
-0.4% -$7.72K 0.01% 872
2019
Q2
$2M Sell
47,300
-36,300
-43% -$1.6M 0.01% 852
2019
Q1
$3.81M Sell
83,600
-2,400
-3% -$110K 0.01% 714
2018
Q4
$3.81M Sell
86,000
-17,500
-17% -$756K 0.02% 676
2018
Q3
$4.88M Buy
103,500
+85,000
+459% +$3.71M 0.02% 683
2018
Q2
$734K Buy
18,500
+7,400
+67% +$315K ﹤0.01% 1074
2018
Q1
$451K Buy
+11,100
New +$412K ﹤0.01% 1183
2015
Q4
Sell
-32,400
Closed -$1.85M 1434
2015
Q3
$1.85M Sell
32,400
-6,000
-16% -$373K 0.01% 786
2015
Q2
$2.54M Buy
38,400
+10,500
+38% +$720K 0.01% 744
2015
Q1
$1.99M Buy
27,900
+15,500
+125% +$1.12M 0.01% 809
2014
Q4
$950K Buy
+12,400
New +$942K ﹤0.01% 970
2014
Q1
Sell
-725
Closed -$53K 1420
2013
Q4
$53K Sell
725
-11,300
-94% -$789K ﹤0.01% 1327
2013
Q3
$789K Buy
12,025
+9,100
+311% +$622K ﹤0.01% 915
2013
Q2
$196K Buy
+2,925
New +$188K ﹤0.01% 1106

Other funds holding GCO

Axa's GCO Position: Q2 2022 in Review

Axa sold out of Genesco (GCO) in Q2 2022, closing a stake of 4,800 shares — an estimated $305K sold.

Axa first reported a position in GCO in Q2 2013 and held it in 20 quarters. The position peaked at $4.88M in Q3 2018. 168 funds tracked by Wall St. Rank hold GCO as of Q2 2022.

  • Axa reported no remaining Genesco position as of Q2 2022 after selling out during the quarter.
  • Axa sold 4,800 Genesco shares in Q2 2022, an estimated $305K.
  • Axa first reported a position in Genesco in Q2 2013 and held it in 20 quarters.
  • Axa's Genesco position peaked at $4.88M in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Genesco as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.